The relationship between a UCSB researcher and several victims of polycystic kidney disease has led to the development of a new designer drug that can travel through the bloodstream to the kidneys of laboratory animals
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease –– although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.
